Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity - a clinical and histological assessment

Oral Diseases

Volumn 18, Issue 8, 2012, Pages 728-733

  Awan, K H ^a,b   Yang, Y H ^c   Morgan, P R ^a   Warnakulasuriya, S ^a,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d King's and St Thomas' School of Medicine and Dentistry   (United Kingdom)

Author keywords

Epithelial dysplasia; Erythroplakia; Leukoplakia; Oral potentially malignant disorders; Toluidine blue

Indexed keywords

TOLONIUM CHLORIDE;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DYSPLASIA; FEMALE; HOSPITAL; HUMAN; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MOUTH MUCOSA; ORAL ERYTHROPLAKIA; PRECANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STOMATOLOGY; UNITED KINGDOM;

ACETIC ACID; ALCOHOL DRINKING; BIOPSY; COLORING AGENTS; CYTODIAGNOSIS; EPITHELIUM; ERYTHROPLASIA; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; SMOKING; TOLONIUM CHLORIDE;

EID: 84866883685     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2012.01935.x     Document Type: Article

References (27)

1. Cancela-Rodriguez P, Carero-Lapiedra R, Esparza-Gomez G, Liamas-Martinez S, Warnakulasuriya S (2011). The use of toluidine blue in the detection of pre-malignant and malignant oral lesions. J Oral Pathol Med40: 300-304.
2. Epstein JB, Guneri P (2009). The adjunctive role of toluidine blue in the detection of oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck Surg17: 79-87.
3. Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E (1997). The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod83: 537-547.
4. Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M (2003). Increased allelic loss in toluidine blue-positive oral premalignant lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod95: 45-50.
5. Gandolfo S, Pentenero M, Broccoletti R, Pagano M, Carrozzo M, Scully C (2006). Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment. Oral Oncol42: 89-95.
6. Guneri P, Epstein JB, Kaya A, Veral A, Kazandi A, Boyacioalu H (2011). The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions. Int J Oral Maxillofac Surg40: 155-161.
7. Kahn MA, Epstein JB (2007). Optimizing the oral cancer evaluation. Compendium28: 3-10.
8. Leston JS, Diz Dios P (2010). Diagnostic clinical aids in oral cancer. Oral Oncol46: 418-422.
9. Lingen MW, Kalmar JR, Karrison T, Speight PM (2008). Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol44: 10-22.
10. Martin IC, Kerawala CJ, Reed M (1998). The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod85: 444-446.
11. Mashberg A (1980). Re-evaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III. Cancer46: 758-763.
12. Mashberg A (1983). Final evaluation of tolonium chloride rinse for screening of highrisk patients with asymptomatic squamous carcinoma. J Am Dent Assoc106: 319-323.
13. Mashberg A, Samit A (1995). Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin45: 328-351.
14. Missmann M, Jank S, Laimer K, Gassner R (2006). A reason for the use of toluidine blue staining in the pre-surgical management of patients with oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod102: 741-743.
15. Myers EN (1970). The toluidine blue test in lesions of the oral cavity. CA Cancer J Clin20: 134-139.
16. Onofre MA, Sposto MR, Navarro CM (2001). Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod91: 535-540.
17. Patton LL (2003). The effectiveness of community-based visual screening and utility of adjunctive diagnostic aids in the early detection of oral cancer. Oral Oncol39: 708-723.
18. Patton LL, Epstein JB, Kerr AR (2008). Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc139: 896-905.
19. Portugal LG, Wilson KM, Biddinger PW, Gluckman JL (1996). The role of toluidine blue in assessing margin status of after resection of squamous cell carcinomas of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg122: 517-519.
20. Su WW, Yen AM, Chiu SY, Chen TH (2010). A community-based RCT for oral cancer screening with toluidine blue. J Dent Res89: 933-937.
21. Vacher C, Legens M, Rueff B, Lezy JP (1999). Despistage des lesions cancereuses et pre-cancereuses de la muqueuse buccale dans une population 'a risque. Rev Stomatol Chir Maxillofac100: 180-183.
22. Van der Waal I (2010). Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management. Oral Oncol46: 423-425.
23. Warnakulasuriya S (2011). Squamous cell carcinoma and precursor lesions: prevention. Periodontology57: 38-50.
24. Warnakulasuriya S, Johnson NW (1996). Sensitivity and specificity of OraScan toluidine blue mouth rinse in the detection of oral cancer and precancer. J Oral Pathol Med25: 97-103.
25. Warnakulasuriya S, Johnson NW, van der Waal I (2007). Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med36: 575-580.
26. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E (2008). Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med37: 127-133.
27. World Health Organization (2005). Classification of Tumours, Pathology & Genetics: head and Neck Tumours. Epithelial precursor lesion. Chapter Authors: Gale N, Pilch BZ, Sidransky D, Estra WH, Califano J. Eds: Banes L, Eveson JW, Reichart P, Sidransky D. IARC Press: Lyon.